inner-banner-bg

Advances in Nutrition & Food Science(ANFS)

ISSN: 2572-5971 | DOI: 10.33140/ANFS

Impact Factor: 1.1

Research Article - (2024) Volume 9, Issue 1

Evaluating Hypericin as A Therapeutic Agent Against Neisseria Gonorrhoeae

Ivan Vito Ferrari *
 
Institute of Clinical Physiology, National Research Council, Via Aurelia Sud, 54100 Massa, Italy
 
*Corresponding Author: Ivan Vito Ferrari, Institute of Clinical Physiology, National Research Council, Via Aurelia Sud, 54100 Massa, Italy

Received Date: Jan 25, 2024 / Accepted Date: Feb 16, 2024 / Published Date: Feb 28, 2024

Copyright: ©©2024 Ivan Vito Ferrari. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation: Ferrari, I. V. (2024), Evaluating Hypericin as A Therapeutic Agent Against Neisseria Gonorrhoeae. Adv Nutr Food Sci, 9(1), 01-03.

Abstract

This study employed molecular docking simulations to investigate potential interactions between natural molecules and the Fe(3+) ions import ATP-binding protein fbpC in Neisseria gonorrhoeae FA 1090. Among the screened molecules, Hy- pericin exhibited a remarkable binding energy of approximately -13.2 kcal/mol, indicating a robust and favorable binding affinity with the target protein. This promising outcome suggests that Hypericin could serve as a potential candidate for further exploration as a therapeutic agent against Neisseria gonorrhoeae infections. However, it is imperative to empha- size that these in silico findings necessitate experimental validation through in vitro and in vivo studies to ascertain the actual efficacy and safety of Hypericin as a treatment option.

Keywords

Hypericin, Neisseria Gonorrhoeae, Docking Analysis, Autodock Vina.

Introduction

Neisseria gonorrhoeae, also known as Neisser's gonococcus, is the causative agent responsible for gonorrhea (or blenorrhagia) [1,2]. This Gram-negative bacterium belongs to the Neisseriaceae family and is morphologically similar to Neisseria meningitidis, the causative agent of meningococcal meningitis. Both are gram-negative cocci that often occur in pairs [1-6]. Neisseria gonorrhoeae is transmitted mainly through sexual contact and can cause a variety of symptoms involving the genital system and, in some cases, other areas such as the throat or anus [1-6]. Increasing resistance to antibiotics has made the management of gonorrhea a challenge, underscoring the importance of safe sexual practices and timely identification and appropriate treatment of infections [1-4].

This Gram-negative diplococcus primarily infects the genital and reproductive tract mucosa but can also affect the throat and rectum [1,2].

Neisseria gonorrhoeae is transmitted through unprotected sexual contact and can lead to a range of symptoms, including genital discharge, pain during urination, and in some cases, complications such as pelvic inflammatory disease [1-6].

The emergence of antibiotic-resistant strains of Neisseria gonorrhoeae has posed challenges for treatment, emphasizing the importance of early detection and appropriate antibiotic therapy. Regular testing, safe sexual practices, and awareness are crucial for preventing and managing infections caused by Neisseria gonorrhoeae [5,6].

Materials and Methods

-Fe(3+) ions import ATP-binding protein fbpC (PDB Code: 3fvq) Grid box Coordinates of binding Center X ( -18,1105), Y( -13,5136), Z(39,4644)

Results and Discussion

This short theoretical computational study based on Molecular Docking [7,9-10] aims to investigate natural molecules against Neisseria gonorrhoea [1-6].

Neisseria gonorrhoeae is a bacterium responsible for the sexually transmitted infection (STI) known as gonorrhea. This bacterium infects the mucous membranes of the reproductive tract, including the cervix, uterus, and fallopian tubes in women, and the urethra in both men and women. It can also infect the throat, rectum, and eyes [1-6].

Gonorrhea is primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Transmission from an infected mother to her child can also occur during childbirth [1-6].

Particular attention docking calculation was performed against Fe(3+) ions import ATP-binding protein fbpC by Neisseria gonorrhoeae [8].

Performing a docking calculation allows to understand the potential binding modes and strength of interaction between the Fe(3+) ions and the fbpC protein [8].

This information can be crucial in understanding the role of this protein in iron import processes in Neisseria gonorrhoeae. Docking analysis was conducted by Mcule Server by Autodock Vina [9,10].

The observation that Hypericin demonstrated an excellent binding energy of about -13.2 kcal/mol against the Fe(3+) ions import ATP-binding protein fbpC in Neisseria gonorrhoeae FA 1090 is noteworthy. A lower binding energy typically indicates a stronger and more stable interaction between the molecule and the target protein.

This calculation suggests its potential utility as a candidate for further exploration in combating Neisseria gonorrhoeae infections.

However, it's important to note that in silico docking studies provide predictions, and experimental validation is crucial to confirm the actual biological activity and effectiveness of Hypericin against Neisseria gonorrhoeae.

Figure 1: displays the docking outcomes of Fe(3+) ions import ATP-binding protein fbpC in conjunction with Hypericin -13.2 kcal/ mol within the Ligand Binding Site, as analyzed by Autodock Vina through the Mcule Database. On the left side, 2D diagrams illustrate the residue interactions between the protein and Hypericin. Meanwhile, the right side exhibits the Ligand Binding Site of the protein, highlighting the specific location of Hypericin.

Conclusion

In conclusion, the molecular docking study revealed that Hypericin exhibits a notable and favorable binding affinity with the Fe(3+) ions import ATP-binding protein fbpC in Neisseria gonorrhoeae FA 1090, as evidenced by a robust binding energy of approximately -13.2 kcal/mol. This finding suggests the potential of Hypericin as a candidate for further investigation as a therapeutic agent against Neisseria gonorrhoeae infections. However, it is crucial to acknowledge that these computational results serve as a preliminary step, and experimental validation through in vitro and in vivo studies is essential to confirm the actual antimicrobial efficacy and safety of Hypericin.

Conflict of interest

The authors declare no conflicts of interest.

References

 

  1. Belcher, T., Rollier, C. S., Dold, C., & MacLennan, C.(2023). Immune responses to Neisseria gonorrhoeae and implications for vaccine development. Frontiers in immunology, 14, 1248613.
  2. Belcher, T., Rollier, C. S., Dold, C., & MacLennan, C.(2023). Immune responses to Neisseria gonorrhoeae and implications for vaccine development. Frontiers in immunology, 14, 1248613.
  3. Vaezzadeh, K., Sepidarkish, M., Mollalo, A., As' adi, N., Rouholamin, S., Rezaeinejad, M., ... & Rostami, A. (2023). Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection, 29(1), 22-31.
  4. Vaezzadeh, K., Sepidarkish, M., Mollalo, A., As' adi, N., Rouholamin, S., Rezaeinejad, M., ... & Rostami, A. (2023). Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection, 29(1), 22-31.Vaezzadeh, K., Sepidarkish, M., Mollalo, A., As' adi, N., Rouholamin, S., Rezaeinejad, M., ... & Rostami, A. (2023). Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection, 29(1), 22-31.
  5. Rubin, D. H., Ma, K. C., Westervelt, K. A., Hullahalli, K., Waldor, M. K., & Grad, Y. H. (2023). CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae.Nature Microbiology, 8(1), 28-39.
  6. Kakooza, F., Kiggundu, R., Mboowa, G., Kateete, P. D., Nsangi, O. T., Kabahita, J. M., ... & Unemo, M. (2023). Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: a mini-review. Frontiers in Microbiology, 14, 1148817.
  7. Azad, I. (2023). Molecular Docking in the Study of Ligand-Protein Recognition: An Overview. Molecular Docking-Recent Advances.
  8. Newstead, S., Fowler, P. W., Bilton, P., Carpenter, E. P., Sadler,P. J., Campopiano, D. J., ... & Iwata, S. (2009). Insights intohow nucleotide-binding domains power ABC transport.Structure, 17(9), 1213-1222.
  9. Odhar, H. A., Rayshan, A. M., Ahjel, S. W., Hashim, A. A., & Albeer, A. A. M. A. (2019). Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors. Bioinformation, 15(9), 627.
  10. Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journa computational chemistry, 31(2), 455-461.